Related Experiment Video
Updated: Mar 8, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.8K
Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
Fabio C M Torricelli1, Denis Jardim2, Giuliano B Guglielmetti2
1Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil.
Summary
Robot-assisted retroperitoneal lymph node dissection (RPLND) is a safe and effective minimally invasive option for non-seminomatous germ cell tumors (NSGCT) with residual disease after chemotherapy. This approach offers feasible outcomes with low morbidity for selected patients.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Retroperitoneal lymph node dissection (RPLND) is crucial for managing non-seminomatous germ cell tumors (NSGCT) with residual disease post-chemotherapy.
- Open surgery remains the standard, but minimally invasive techniques are emerging.
